APA aipamena

Dayyani, F., Zurita, A. J., Nogueras-González, G. M., Slack, R., Millikan, R. E., Araujo, J. C., . . . Corn, P. G. (2016). The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study. BMC Cancer.

Chicago Style aipamena

Dayyani, Farshid, Amado J. Zurita, Graciela M. Nogueras-González, Rebecca Slack, Randall E. Millikan, John C. Araujo, Gary E. Gallick, Christopher J. Logothetis, and Paul G. Corn. "The Combination of Serum Insulin, Osteopontin, and Hepatocyte Growth Factor Predicts Time to Castration-resistant Progression in Androgen Dependent Metastatic Prostate Cancer- an Exploratory Study." BMC Cancer 2016.

MLA aipamena

Dayyani, Farshid, et al. "The Combination of Serum Insulin, Osteopontin, and Hepatocyte Growth Factor Predicts Time to Castration-resistant Progression in Androgen Dependent Metastatic Prostate Cancer- an Exploratory Study." BMC Cancer 2016.